Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Incyte Corporation - Common Stock
(NQ:
INCY
)
102.52
+2.06 (+2.05%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,357,052
Open
101.00
Bid (Size)
102.55 (500)
Ask (Size)
105.00 (16,000)
Prev. Close
100.46
Today's Range
98.36 - 103.68
52wk Range
53.56 - 109.28
Shares Outstanding
222,430,635
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
Today 9:30 EST
From
Incyte
Via
Business Wire
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
Today 9:30 EST
From
Incyte
Via
Business Wire
Performance
YTD
+47.4%
+47.4%
1 Month
-2.5%
-2.5%
3 Month
+18.4%
+18.4%
6 Month
+46.7%
+46.7%
1 Year
+35.0%
+35.0%
More News
Read More
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2025
From
Incyte Corporation
Via
Business Wire
2 S&P 500 Stocks Worth Investigating and 1 We Brush Off
December 03, 2025
Via
StockStory
Topics
Stocks
Incyte and Winnie Harlow Join Forces to Share Her Personal Vitiligo Story and Spark Conversation and Understanding
December 02, 2025
From
Incyte
Via
Business Wire
Gapping S&P500 stocks in Monday's session
↗
December 01, 2025
Via
Chartmill
Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel
December 01, 2025
From
Incyte
Via
Business Wire
Top S&P500 movers in Friday's session
↗
November 28, 2025
Via
Chartmill
Gapping S&P500 stocks in Friday's session
↗
November 28, 2025
Via
Chartmill
INCYTE CORP (NASDAQ:INCY) Fits Minervini Trend Template with Strong Growth Momentum
↗
November 26, 2025
Via
Chartmill
2 Growth Stocks Set to Flourishand 1 Facing Challenges
November 25, 2025
Via
StockStory
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know
November 24, 2025
Via
StockStory
Topics
Economy
Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks
November 23, 2025
Via
StockStory
Topics
Artificial Intelligence
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
November 20, 2025
Via
StockStory
Spotting Winners: Natera (NASDAQ:NTRA) And Immuno-Oncology Stocks In Q3
November 19, 2025
Via
StockStory
Topics
Artificial Intelligence
Incyte to Present at Upcoming Investor Conferences
November 19, 2025
From
Incyte
Via
Business Wire
Top S&P500 movers in Tuesday's pre-market session
↗
November 18, 2025
Via
Chartmill
INCYTE CORP (NASDAQ:INCY) Presents a Compelling Case for Value Investors
↗
November 18, 2025
Via
Chartmill
This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why
↗
November 18, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally
↗
November 18, 2025
Via
The Motley Fool
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks
↗
November 14, 2025
Via
Benzinga
Topics
Artificial Intelligence
1 Mid-Cap Stock to Consider Right Now and 2 We Turn Down
November 13, 2025
Via
StockStory
Peering Into Incyte Corp's Recent Short Interest
↗
November 12, 2025
Via
Benzinga
Incyte (NASDAQ:INCY) Q3 Earnings: Leading The Immuno-Oncology Pack
November 10, 2025
Via
StockStory
Topics
Artificial Intelligence
Winners And Losers Of Q3: Regeneron (NASDAQ:REGN) Vs The Rest Of The Immuno-Oncology Stocks
November 10, 2025
Via
StockStory
Topics
Artificial Intelligence
Frequently Asked Questions
Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 102.52
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 12/05/25 04:00 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 22.80B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 23B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.